Volume 8, Issue 5, Pages (May 1998)

Slides:



Advertisements
Similar presentations
Volume 6, Issue 4, Pages (April 1997)
Advertisements

The T Cell Surface—How Well Do We Know It?
Volume 9, Issue 5, Pages (November 1998)
Volume 13, Issue 2, Pages (August 2000)
Teshome Mebatsion, Matthias König, Karl-Klaus Conzelmann  Cell 
Characterization of assembly of recombinant type IV collagen α3, α4, and α5 chains in transfected cell strains  Takehiro Kobayashi, Makoto Uchiyama  Kidney.
Antigen Presenting Phenotype of Hodgkin Reed-Sternberg Cells: Analysis of the HLA Class I Processing Pathway and the Effects of Interleukin-10 on Epstein-Barr.
Mature dendritic cells pulsed with freeze–thaw cell lysates define an effective in vitro vaccine designed to elicit EBV-specific CD4+ and CD8+ T lymphocyte.
Volume 7, Issue 6, Pages (December 1997)
Volume 14, Issue 5, Pages (May 2001)
Volume 6, Issue 5, Pages (May 1997)
Specific Lysis of Melanoma Cells by Receptor Grafted T Cells is Enhanced by Anti- Idiotypic Monoclonal Antibodies Directed to the scFv Domain of the Receptor 
Volume 4, Issue 5, Pages (May 1996)
Volume 6, Issue 5, Pages (November 2009)
Biochemical Mechanisms of IL-2–Regulated Fas-Mediated T Cell Apoptosis
Volume 6, Issue 2, Pages (February 1997)
Volume 16, Issue 4, Pages (April 1996)
Volume 8, Issue 1, Pages 1-10 (January 1998)
Volume 5, Issue 2, Pages (August 1996)
Ananda W Goldrath, Michael J Bevan  Immunity 
Volume 11, Issue 2, Pages (August 1999)
Volume 6, Issue 1, Pages (January 1997)
Elias T. Spiliotis, Manuel Osorio, Martha C. Zúñiga, Michael Edidin 
Lamp-2a Facilitates MHC Class II Presentation of Cytoplasmic Antigens
The Pathway for Processing Leader-Derived Peptides that Regulate the Maturation and Expression of Qa-1b  Ailin Bai, James Broen, James Forman  Immunity 
Volume 5, Issue 2, Pages (August 1996)
MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α
Volume 16, Issue 1, Pages (January 2002)
Tobias P Dick, Naveen Bangia, David R Peaper, Peter Cresswell  Immunity 
Volume 20, Issue 1, Pages (January 2004)
Paul J Lehner, Michael J Surman, Peter Cresswell  Immunity 
MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α
Volume 3, Issue 3, Pages (March 1999)
Volume 6, Issue 6, Pages (June 1997)
Site α Is Crucial for Two Routes of IFNγ-Induced MHC Class I Transactivation: The ISRE-Mediated Route and a Novel Pathway Involving CIITA  Sam J.P Gobin,
CD46 Is a Cellular Receptor for Human Herpesvirus 6
Volume 11, Issue 5, Pages (November 1999)
Volume 6, Issue 1, Pages (January 1997)
Association Between HLA-DM and HLA-DR In Vivo
ER Stress Regulation of ATF6 Localization by Dissociation of BiP/GRP78 Binding and Unmasking of Golgi Localization Signals  Jingshi Shen, Xi Chen, Linda.
Volume 84, Issue 4, Pages (February 1996)
Volume 15, Issue 6, Pages (December 2001)
The Gemin5 Protein of the SMN Complex Identifies snRNAs
Volume 96, Issue 3, Pages (February 1999)
Volume 14, Issue 5, Pages (May 2001)
TopBP1 Activates the ATR-ATRIP Complex
Volume 127, Issue 2, Pages (October 2006)
Volume 17, Issue 5, Pages (November 2002)
Effects of a Single Escape Mutation on T Cell and HIV-1 Co-adaptation
Volume 11, Issue 4, Pages (February 2001)
Volume 4, Issue 6, Pages (June 1996)
Negative Selection at the Pre-BCR Checkpoint Elicited by Human μ Heavy Chains with Unusual CDR3 Regions  Yoshiyuki Minegishi, Mary Ellen Conley  Immunity 
Volume 18, Issue 2, Pages (February 2003)
Molecular Therapy - Oncolytics
Volume 7, Issue 4, Pages (October 1997)
Volume 8, Issue 2, Pages (February 1998)
Volume 4, Issue 4, Pages (October 1999)
Volume 7, Issue 6, Pages (December 1997)
Dissecting the Multifactorial Causes of Immunodominance in Class I–Restricted T Cell Responses to Viruses  Weisan Chen, Luis C. Antón, Jack R. Bennink,
N-Terminal Palmitoylation of PSD-95 Regulates Association with Cell Membranes and Interaction with K+ Channel Kv1.4  J.Rick Topinka, David S Bredt  Neuron 
Elias T. Spiliotis, Manuel Osorio, Martha C. Zúñiga, Michael Edidin 
Volume 6, Issue 2, Pages (February 1997)
The differential susceptibility to CTL-induced lysis does not involve Melan-A antigen expression. The differential susceptibility to CTL-induced lysis.
Volume 15, Issue 2, Pages (August 2001)
Activation of the Lck Tyrosine Kinase Targets Cell Surface T Cell Antigen Receptors for Lysosomal Degradation  Ugo D'Oro, Melanie S Vacchio, Allan M Weissman,
Volume 33, Issue 5, Pages (March 2009)
Unassembled Ig Heavy Chains Do Not Cycle from BiP In Vivo but Require Light Chains to Trigger Their Release  Marc Vanhove, Young-Kwang Usherwood, Linda.
Differences that Matter
Volume 7, Issue 6, Pages (December 1997)
Virus Subversion of the MHC Class I Peptide-Loading Complex
Presentation transcript:

Volume 8, Issue 5, Pages 531-542 (May 1998) HLA-B27–Restricted Antigen Presentation in the Absence of Tapasin Reveals Polymorphism in Mechanisms of HLA Class I Peptide Loading  Chen Au Peh, Scott R Burrows, Megan Barnden, Rajiv Khanna, Peter Cresswell, Denis J Moss, James McCluskey  Immunity  Volume 8, Issue 5, Pages 531-542 (May 1998) DOI: 10.1016/S1074-7613(00)80558-0

Figure 1 Polymorphism in the Expression Level and Maturation Kinetics of Cell Surface HLA Class I Molecules Expressed in Murine Cells (A) Mouse L cells expressing human β2m (J26) were transfected with DNA encoding the heavy chains of either HLA B*2705, B8, or B*4402 and stained by indirect immunofluorescence using mAb W6/32 (anti-HLA class I). FACS histograms are shown for cells cultured at 37°C (dotted lines) and 26°C (solid lines). Jurkat cells were transfected with DNA encoding HLA B*4402 (bottom) and stained with 116.5.28 antibody (anti-Bw4). Staining of untransfected J26 or Jurkat cells is shown in the filled histograms. (B) The indicated cells were pulsed labeled with [35S]methionine for 5 min and chased in excess cold methionine for 30, 60, or 90 min. Labeled B*4402 and B*2705 heavy chains were recovered, and a sample from each time point was either digested with endoglycosidase-H (+) or mock digested (−) overnight. Proteins were separated by SDS-PAGE in a 10% gel. Endoglycosidase-H–sensitive (S) and –resistant (R) protein bands are indicated by arrowheads. Immunity 1998 8, 531-542DOI: (10.1016/S1074-7613(00)80558-0)

Figure 2 Introduction of the Human Tapasin Gene Restores Efficient Maturation, Transport, and Surface Expression of HLA Class I Molecules in Mouse Cells (A) J26 cells expressing HLA B*2705, B8, or B*4402 were transfected with the human tapasin gene and stained by indirect immunofluorescence with mAb W6/32 after incubation at 37°C. Flow cytometric histograms of the tapasin-negative (dotted lines) and tapasin-positive cells (solid lines) are shown. Staining of untransfected J26 cells is shown in the filled histograms. The increment in surface HLA expression following tapasin transfection was calculated from peak channel fluorescence values and indicated for each of the paired histograms. (B) J26 cells expressing HLA B*4402 in the absence (J26.B4402) or presence (J26.B4402.hTapasin) of human tapasin were pulse labeled with [35S]methionine for 5 min. HLA complexes were immunoprecipitated with mAb W6/32, dissociated in SDS buffer, and digested either with endoglycosidase-H (+) or mock digested (−) overnight. The digested proteins were separated by 10% SDS-PAGE and autoradiographed after fluorography. Chase times are indicated, and endoglycosidase-H–sensitive (S) and resistant (R) protein bands are indicated by arrowheads. Immunity 1998 8, 531-542DOI: (10.1016/S1074-7613(00)80558-0)

Figure 3 HLA Class I Molecules Show a Spectrum of Tapasin Dependence for Efficient Surface Expression in Human Cells Transfected tapasin-defective 721.220 cells expressing either HLA B*2705, B8, or B*4402 were cotransfected with a human tapasin cDNA. Stable transfectants either expressing (solid lines) or lacking (dotted lines) human tapasin were stained by indirect immunofluorescence with mAb 116.5.28 (anti-Bw4) to detect B*2705 and B*4402 expression or with mAb 126.39 (anti-Bw6) to detect B8 expression. All cells were incubated at 37°C. Staining of untransfected 721.220 cells is shown by the filled histograms. The increment in surface HLA expression following tapasin transfection was calculated from peak channel fluorescence values and indicated for each of the paired histograms. Immunity 1998 8, 531-542DOI: (10.1016/S1074-7613(00)80558-0)

Figure 4 Tapasin Expression Enhances the Association of Both HLA B*2705 and B*4402 Molecules with TAP Equal numbers of the indicated cells were labeled with [35S]methionine for 15 min and lysed in digitonin buffer. Immunoprecipitates were formed with mAb 148.3 (anti-TAP1), bound to protein A sepharose beads and washed. Immune complexes were then dissociated from the protein A–sepharose beads in SDS buffer and eluted proteins were reacted with mAb HC-10 (anti-HLA free heavy chains). The new immune complexes were separated by 10% SDS-PAGE and autoradiographed after fluorography. The position of HLA class I heavy chains (HC) is indicated by an arrowhead. Cell lines studied were Jurkat (positive control), T2 (a TAP-negative human LCL; negative control), 721.220 (parental tapasin-negative LCL), 721.220.Tapasin (721.220 transfectant expressing tapasin alone), 721.220.B*2705 (721.220 transfectant expressing HLA B*2705), 721.220.B*4402 (721.220 transfectant expressing HLA B*4402), 721.220.B*2705.Tapasin (721.220 transfectant expressing HLA B*2705 plus tapasin), and 721.220.B*4402.Tapasin (721.220 transfectant expressing HLA B*4402 plus tapasin). Immunity 1998 8, 531-542DOI: (10.1016/S1074-7613(00)80558-0)

Figure 5 Allelic Polymorphism in the Efficiency of HLA Class I–Restricted Presentation of Specific Viral Peptides by Tapasin-Deficient Cells Cytotoxicity assays were carried out on target cells incubated with EBV-specific CTL clones. Killing of the target cells was measured by specific 51Cr release. (A) CTL clone SE2 was derived from a HLA-B*4403 positive donor but recognizes the EBNA4 peptide VEITPYKPTW when presented by either HLA-B*4403 or B*4402, E:T ratio 2:1. (B) CTL clone LC15 recognizes the EBNA3 peptide QAKWRLQTL presented by HLA-B8, E:T ratio 0.3:1. (C) CTL clone LC13 recognizes the FLRGRAYGL peptide of EBNA3 also presented by HLA-B8, E:T ratio 2:1. (D) CTL clone BT7 recognizes the EBNA4 peptide HRCQAIRKK presented by HLA-B*2705, E:T ratio 1:1. Targets included untransfected 721.220 cells, HLA-B homozygous LCLs, and 721.220 cells expressing the indicated HLA-B molecules with and without human tapasin. Targets were either untreated, loaded with the indicated EBV peptide or infected with control (Vacc.TK−) or recombinant vaccinia virus expressing the indicated EBV antigen (Vacc.EBNA3/4). Vaccinia infections proceeded for 4 or 12 hr before the assay. In (D), the CTL lysis assay against targets infected for 4 hr with Vacc.EBNA4 was carried out separately from the other targets. Immunity 1998 8, 531-542DOI: (10.1016/S1074-7613(00)80558-0)

Figure 6 An Altered Repertoire of Peptides Is Selected for Presentation by HLA B*2705 Molecules Expressed in the Absence of Tapasin (A) 721.220 cells expressing B*2705 in the presence (+) or absence (−) of human tapasin and the TAP-deletion mutant T2 expressing B*2705 were stained with the indicated HLA class I–specific mAbs by indirect immunofluorescence. Cells were cultured at 37°C, and the filled histograms represent staining of untransfected 721.220 or T2 cells. (B) B*2705 expressing 721.220 tranfectants with (721.220.B*2705.tapasin) and without (721.220.B*2705) tapasin were stained by indirect immunofluorescence with the mAb HC-10, which recognized free heavy-chain epitopes. Cell surface expression of free heavy chain on 721.220.B*2705 was reexamined after overnight incubation with either 10 μM of a B*2705-binding peptide HRCQAIRKK or irrelevant peptide. All cells were cultured at 37°C. The filled histogram indicates staining of untransfected 721.220 cells and 721.220 cells transfected with tapasin alone. Immunity 1998 8, 531-542DOI: (10.1016/S1074-7613(00)80558-0)